International trade · 04/10/2016

U.S. International Trade Commission Terminates Investigation into Certain Recombinant Factor VIII Products

The U.S. International Trade Commission has agreed to end its investigation into recombinant factor VIII products following a settlement agreement, as announced in a public notice on the ITC website (https://www.usitc.gov/).